APP
REPL icon

Alpha Paradigm Partners’s Replimune Group REPL Stock Holding History

Alpha Paradigm Partners’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$739K Buy
+27,156
New +$564K 0.31% 116

Other funds holding REPL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alpha Paradigm Partners's REPL Position: Q4 2022 in Review

Alpha Paradigm Partners opened a new position in Replimune Group (REPL) in Q4 2022: 27,156 shares worth $739K. The stake represents 0.31% of the portfolio and ranks #116 among its holdings.

135 funds tracked by Wall St. Rank hold REPL as of Q4 2022.

  • Alpha Paradigm Partners held 27,156 shares of Replimune Group worth $739K as of Q4 2022.
  • Replimune Group was a new Alpha Paradigm Partners position in Q4 2022.
  • Replimune Group made up 0.31% of Alpha Paradigm Partners's portfolio in Q4 2022, its #116 holding.
  • 135 funds tracked by Wall St. Rank held Replimune Group as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.